Actinogen Medical Limited (AU:ACW) has released an update.
Actinogen Medical Limited has announced a new securities purchase plan, proposing the issue of 75 million listed options and 100 million ordinary shares, with an offer closing date set for October 8, 2024. The record date for the proposed issue is September 17, 2024, and the issue date is planned for October 10, 2024. This move is aimed at expanding the company’s financial capabilities and underlines its growth strategy.
For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.
